Ameriprise Financial Inc Arcturus Therapeutics Holdings Inc. Transaction History

Ameriprise Financial Inc

$388 Billion
Q2 2025

A detailed history of Ameriprise Financial Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 72,252 shares of ARCT stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,252

Previous 15,100 378.49%

Holding current value

$1.08 Million

Previous $159,000 490.57%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.91 - $14.41 $509,224 - $823,560	57,152 Added 378.49%	72,252 $939,000
Q1 2025 May 14, 2025	SELL	$10.59 - $20.83 $37,202 - $73,175	-3,513 Reduced 18.87%	15,100 $159,000
Q4 2024 Feb 14, 2025	BUY	$14.82 - $25.48 $13,086 - $22,498	883 Added 4.98%	18,613 $315,000
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $26,396 - $37,054	-1,460 Reduced 7.61%	17,730 $411,000
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $31,776 - $57,928	1,305 Added 7.3%	19,190 $467,000
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $229,321 - $315,675	-7,343 Reduced 29.11%	17,885 $603,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $291,205 - $542,125	16,443 Added 187.17%	25,228 $795,000
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $3,510 - $5,154	-138 Reduced 1.55%	8,785 $224,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $2,753 - $3,721	115 Added 1.31%	8,923 $255,000
Q1 2023 May 15, 2023	SELL	$14.72 - $23.97 $98,947 - $161,126	-6,722 Reduced 43.28%	8,808 $211,000
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $21,351 - $34,820	1,510 Added 10.77%	15,530 $263,000
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $182,961 - $310,262	14,020 New	14,020 $208,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $199,386 - $277,274	-5,830 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $162,540 - $339,597	5,830 New	5,830 $279,000
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $370,411 - $830,868	-9,559 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$34.61 - $123.66 $1.62 Million - $5.78 Million	-46,765 Reduced 83.03%	9,559 $415,000
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $524,035 - $883,269	-13,978 Reduced 19.88%	56,324 $2.42 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $890,023 - $4.1 Million	70,302 New	70,302 $3.29 Million

Others Institutions Holding ARCT

# of Institutions

169

Shares Held

25.9M

Call Options Held

289K

Put Options Held

109K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $396M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Arcturus Therapeutics Holdings Inc. Transaction History